These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 10487624)
1. p22/WAF1 expression in human colorectal carcinoma: association with p53, transcription factor AP-2 and prognosis. Ropponen KM; Kellokoski JK; Lipponen PK; Pietiläinen T; Eskelinen MJ; Alhava EM; Kosma VM Br J Cancer; 1999 Sep; 81(1):133-40. PubMed ID: 10487624 [TBL] [Abstract][Full Text] [Related]
2. Expression of cyclins A and D and p21(waf1/cip1) proteins in renal cell cancer and their relation to clinicopathological variables and patient survival. Aaltomaa S; Lipponen P; Ala-Opas M; Eskelinen M; Syrjänen K; Kosma VM Br J Cancer; 1999 Aug; 80(12):2001-7. PubMed ID: 10471053 [TBL] [Abstract][Full Text] [Related]
3. p53, p21 and p27 protein expression in head and neck cancer and their prognostic value. Kapranos N; Stathopoulos GP; Manolopoulos L; Kokka E; Papadimitriou C; Bibas A; Yiotakis J; Adamopoulos G Anticancer Res; 2001; 21(1B):521-8. PubMed ID: 11299798 [TBL] [Abstract][Full Text] [Related]
4. Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67. Tut VM; Braithwaite KL; Angus B; Neal DE; Lunec J; Mellon JK Br J Cancer; 2001 Jan; 84(2):270-5. PubMed ID: 11161387 [TBL] [Abstract][Full Text] [Related]
5. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features. Ioachim E Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860 [TBL] [Abstract][Full Text] [Related]
6. p53 and p21 Expression levels predict organ preservation and survival in invasive bladder carcinoma treated with a combined-modality approach. Garcia del Muro X; Condom E; Vigués F; Castellsagué X; Figueras A; Muñoz J; Solá J; Soler T; Capellà G; Germà JR Cancer; 2004 May; 100(9):1859-67. PubMed ID: 15112266 [TBL] [Abstract][Full Text] [Related]
7. The prognostic significance of p53, p21 (Waf1/Cip1), and cyclin D1 protein expression in esophageal cancer patients. Hirai T; Kuwahara M; Yoshida K; Osaki A; Toge T Anticancer Res; 1999; 19(5C):4587-91. PubMed ID: 10650815 [TBL] [Abstract][Full Text] [Related]
8. p21WAF1 expression is associated with improved survival after adjuvant chemoradiation for pancreatic cancer. Ahrendt SA; Brown HM; Komorowski RA; Zhu YR; Wilson SD; Erickson BA; Ritch PS; Pitt HA; Demeure MJ Surgery; 2000 Oct; 128(4):520-30. PubMed ID: 11015084 [TBL] [Abstract][Full Text] [Related]
9. p21/WAF1 expression as related to p53, cell proliferation and prognosis in epithelial ovarian cancer. Anttila MA; Kosma VM; Hongxiu J; Puolakka J; Juhola M; Saarikoski S; Syrjänen K Br J Cancer; 1999 Apr; 79(11-12):1870-8. PubMed ID: 10206307 [TBL] [Abstract][Full Text] [Related]
10. p53 and p21 expression in precancerous lesions and carcinomas of the uterine cervix: overexpression of p53 predicts poor disease outcome. Huang LW; Chou YY; Chao SL; Chen TJ; Lee TT Gynecol Oncol; 2001 Nov; 83(2):348-54. PubMed ID: 11606096 [TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical study of cell cycle-associated proteins in adenocarcinoma of the uterine cervix treated with radiotherapy alone: P53 status has a strong impact on prognosis. Suzuki Y; Nakano T; Kato S; Ohno T; Tsujii H; Oka K Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):231-6. PubMed ID: 15337561 [TBL] [Abstract][Full Text] [Related]
12. P21 (WAF1) expression in colorectal cancer: correlation with P53 and cyclin D1 expression, clinicopathological parameters and prognosis. Pasz-Walczak G; Kordek R; Faflik M Pathol Res Pract; 2001; 197(10):683-9. PubMed ID: 11700890 [TBL] [Abstract][Full Text] [Related]
13. Low levels of insulin-like growth factor type 1 receptor expression at cancer cell membrane predict liver metastasis in Dukes' C human colorectal cancers. Nakamura M; Miyamoto S; Maeda H; Zhang SC; Sangai T; Ishii G; Hasebe T; Endoh Y; Saito N; Asaka M; Ochiai A Clin Cancer Res; 2004 Dec; 10(24):8434-41. PubMed ID: 15623623 [TBL] [Abstract][Full Text] [Related]
14. Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER2, and prognosis. Pellikainen JM; Ropponen KM; Kataja VV; Kellokoski JK; Eskelinen MJ; Kosma VM Clin Cancer Res; 2004 Nov; 10(22):7621-8. PubMed ID: 15569994 [TBL] [Abstract][Full Text] [Related]
15. p21WAF1/CIP1 expression in colorectal carcinoma correlates with advanced disease stage and p53 mutations. Viale G; Pellegrini C; Mazzarol G; Maisonneuve P; Silverman ML; Bosari S J Pathol; 1999 Feb; 187(3):302-7. PubMed ID: 10398083 [TBL] [Abstract][Full Text] [Related]
16. P21/WAF1 is an independent survival prognostic factor for patients with hepatocellular carcinoma after resection. Kao JT; Chuah SK; Huang CC; Chen CL; Wang CC; Hung CH; Chen CH; Wang JH; Lu SN; Lee CM; Changchien CS; Hu TH Liver Int; 2007 Aug; 27(6):772-81. PubMed ID: 17617120 [TBL] [Abstract][Full Text] [Related]
17. Mutated p53 protein expression and proliferative activity in advanced gastric cancer. Ikeguchi M; Saito H; Kondo A; Tsujitani S; Maeta M; Kaibara N Hepatogastroenterology; 1999; 46(28):2648-53. PubMed ID: 10522058 [TBL] [Abstract][Full Text] [Related]
18. p21 (WAF1/CIP1) protein expression is associated with prolonged survival but not with p53 expression in epithelial ovarian carcinoma. Schmider A; Gee C; Friedmann W; Lukas JJ; Press MF; Lichtenegger W; Reles A Gynecol Oncol; 2000 May; 77(2):237-42. PubMed ID: 10785471 [TBL] [Abstract][Full Text] [Related]
19. Expression of bcl-2, c-erbB-2, p53, and p21 (waf1-cip1) protein in thyroid carcinomas. Soda G; Antonaci A; Bosco D; Nardoni S; Melis M J Exp Clin Cancer Res; 1999 Sep; 18(3):363-7. PubMed ID: 10606183 [TBL] [Abstract][Full Text] [Related]
20. Evidence for a dose-response effect between p53 (but not p21WAF1/Cip1) protein concentrations, survival, and responsiveness in patients with epithelial ovarian cancer treated with platinum-based chemotherapy. Levesque MA; Katsaros D; Massobrio M; Genta F; Yu H; Richiardi G; Fracchioli S; Durando A; Arisio R; Diamandis EP Clin Cancer Res; 2000 Aug; 6(8):3260-70. PubMed ID: 10955812 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]